Suppr超能文献

相似文献

1
Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
Eur J Immunol. 2011 May;41(5):1480-1490. doi: 10.1002/eji.201040890. Epub 2011 Apr 20.
2
β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
Diabetes. 2013 Nov;62(11):3775-84. doi: 10.2337/db13-0669. Epub 2013 Jul 24.
4
L-selectin is not required for T cell-mediated autoimmune diabetes.
J Immunol. 2002 Mar 15;168(6):2659-66. doi: 10.4049/jimmunol.168.6.2659.
7
ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice.
J Immunol. 2012 Feb 1;188(3):1064-74. doi: 10.4049/jimmunol.1101303. Epub 2012 Jan 6.
9
Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
J Exp Med. 2007 Jan 22;204(1):191-201. doi: 10.1084/jem.20061631. Epub 2007 Jan 8.
10
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.
J Clin Invest. 2010 Dec;120(12):4558-68. doi: 10.1172/JCI42945. Epub 2010 Nov 22.

引用本文的文献

2
β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
Eur J Immunol. 2017 Jan;47(1):144-154. doi: 10.1002/eji.201646493. Epub 2016 Nov 25.
3
Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.
Immunol Cell Biol. 2016 May;94(5):509-19. doi: 10.1038/icb.2016.7. Epub 2016 Jan 14.
4
IL-Y, a synthetic member of the IL-12 cytokine family, suppresses the development of type 1 diabetes in NOD mice.
Eur J Immunol. 2015 Nov;45(11):3114-25. doi: 10.1002/eji.201445403. Epub 2015 Sep 1.
5
IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
Clin Exp Immunol. 2015 Oct;182(1):90-100. doi: 10.1111/cei.12668. Epub 2015 Jul 30.
6
Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity.
Int J Mol Sci. 2014 Oct 15;15(10):18574-92. doi: 10.3390/ijms151018574.
10
Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression.
J Immunol. 2013 Dec 1;191(11):5460-76. doi: 10.4049/jimmunol.1301576. Epub 2013 Oct 25.

本文引用的文献

2
Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus.
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19438-43. doi: 10.1073/pnas.0903561106. Epub 2009 Oct 30.
3
4
Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mouse.
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11236-40. doi: 10.1073/pnas.0904780106. Epub 2009 Jun 22.
5
Interleukin-21 is required for the development of type 1 diabetes in NOD mice.
Diabetes. 2009 May;58(5):1144-55. doi: 10.2337/db08-0882. Epub 2009 Feb 10.
6
The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19857-62. doi: 10.1073/pnas.0810713105. Epub 2008 Dec 10.
7
Cutting edge: the Idd3 genetic interval determines regulatory T cell function through CD11b+CD11c- APC.
J Immunol. 2008 Dec 1;181(11):7449-52. doi: 10.4049/jimmunol.181.11.7449.
9
IL-21 signaling is critical for the development of type I diabetes in the NOD mouse.
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14028-33. doi: 10.1073/pnas.0804358105. Epub 2008 Sep 8.
10
IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms.
PLoS One. 2008 Sep 5;3(9):e3118. doi: 10.1371/journal.pone.0003118.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验